Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Discover which credit card offers the best cash back for diverse spending. Make informed choices to maximize your rewards!
27,144 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Investors weigh geopolitical risk as oil prices rise and trading desks debate the feasibility of reopening Hormuz, wi...
Three months into 2026, the 2.8% COLA boosted average benefits to $2,071, but a surge in energy prices and Medicare w...
May 2026 data show mortgage lock volume slid 9% from April as higher rates cooled demand. Purchases led the market, w...
Tether converts a historic $13 billion profit into a bold health-tech investment, backing Eight Sleep at a $1.5 billi...
Midwest cities are drawing new capital as Sun Belt rents retreat and new supply cools the boom. The belt boom over. m...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
SanDisk and Micron surge on AI memory demand, prompting a renewed debate on whether to buy, sell, or hold as fundamen...
Palo Alto Networks fell sharply after reporting a solid Q2 on earnings but guiding Q3 profits below expectations. The...
California's governor signs a bold policy to curb insider moves in prediction markets. The move, framed as protecting...
Oracle stock is under pressure amid a tech-wide selloff, but a massive AI backlog could provide durable revenue and u...
Ford faces a turning point as it expands EV capabilities while navigating a volatile market. Here are three scenarios...